February 27, 2026
Headlines

Ensysce Biosciences Stock Doubles In One Trading Session – Here’s Why

Sumain Faisal01 mins

Ensysce Biosciences rises after patent notice for PF9001, a methadone prodrug aimed at safer opioid use with overdose protection technology.

read more

Leave a Reply

Your email address will not be published. Required fields are marked *

Related News